Perform differential expression analysis using edgeR in R/Bioconductor. Use for analyzing RNA-seq count data with the quasi-likelihood F-test framework, creating DGEList objects, normalization, dispersion estimation, and statistical testing. Use when performing DE analysis with edgeR.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Work with FASTQ quality scores using Biopython. Use when analyzing read quality, filtering by quality, trimming low-quality bases, or generating quality reports.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Comprehensive variant filtering including GATK VQSR, hard filters, bcftools expressions, and quality metric interpretation for SNPs and indels. Use when filtering variants using GATK best practices.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Perform flux balance analysis (FBA) and flux variability analysis (FVA) on genome-scale metabolic models using COBRApy. Predict growth rates, metabolic fluxes, and optimal resource utilization. Use when predicting metabolic phenotypes or optimizing flux distributions.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Maps GWAS-implicated loci to candidate effector (causal) genes by integrating variant-to-gene (V2G) features via Open Targets L2G (Mountjoy 2021), MAGMA gene-based association (de Leeuw 2015), FUMA SNP2GENE, cS2G combined SNP-to-gene scores (Gazal 2022), Polygenic Priority Scores (PoPS, Weeks 2023), FLAMES, INQUISIT, DEPICT, and enhancer-gene predictors (ABC, ENCODE-rE2G). Use when narrowing a GWAS lead locus to a candidate causal gene, picking between proximity, eQTL-based, and similarity-based prioritizers, integrating multi-evidence streams (fine-mapping, colocalization, ABC enhancer-gene, distance, chromatin), reconciling discordant L2G vs PoPS calls, prioritizing tissue-specific eQTL evidence, or triangulating across at least three independent lines of evidence for a publication-grade effector-gene nomination.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
End-to-end eDNA metabarcoding from raw amplicons to community ecology. Covers QC, primer removal, denoising with OBITools3 or DADA2, contamination filtering, taxonomy assignment, Hill number diversity, and constrained ordination. Use when processing environmental DNA samples for biodiversity assessment or ecological surveys.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Query the Ensembl REST API for gene/transcript/protein lookup, sequence retrieval, comparative genomics (Compara), variant effect prediction (VEP), regulatory features, and cross-species ortholog/paralog calls. Use when pulling Ensembl-native data (Ensembl Gene IDs, version-pinned releases, archive endpoints for reproducibility), gene/transcript/exon structure with stable IDs, or VEP for variant annotation. Encodes the 15 req/sec rate limit, archive (e110.rest.ensembl.org) for reproducibility, Ensembl divisions (vertebrates / plants / fungi / metazoa / bacteria), and the symbol-vs-ID stability problem.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Analyzes CRISPR drug-modifier (chemogenomic) screens with drugZ (Li & Hart 2019 Genome Med), a bidirectional Z-score method that identifies synthetic-lethal sensitizing genes and resistance-conferring suppressor genes from vehicle vs drug comparisons. Covers vehicle-anchored design (not Day-0), the bidirectional Z math giving 2-3x sensitivity over MAGeCK / STARS / edgeR / RIGER on drug screens, per-gene sumZ and normZ, synth (sensitizer) vs supp (suppressor) FDR, multi-dose handling, integration with control sgRNAs, and comparison with MAGeCK MLE with dose covariate. Use when running a drug-modifier CRISPR screen, identifying sensitizing or resistance genes for a drug candidate, choosing drugZ vs MAGeCK MLE for chemogenomic analysis, troubleshooting low-effect drug screens where MAGeCK lacks sensitivity, or designing a drug-screen layout (vehicle vs drug arms).
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Resolve the architecture of focal oncogene amplifications — extrachromosomal DNA (ecDNA), breakage-fusion-bridge (BFB) cycles, homogeneously staining regions (HSR), and linear amplification — from whole-genome sequencing with AmpliconArchitect, the AmpliconSuite pipeline, and AmpliconClassifier. Covers copy-number seed selection, breakpoint-graph reconstruction, balanced-flow optimization, ecDNA classification, and the limits of depth-only amplification calls. Use when a focal amplification needs structural characterization, when distinguishing ecDNA from chromosomal amplification, suspecting ecDNA-driven oncogene amplification or therapy resistance, or selecting copy-number seeds for amplicon reconstruction.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Computes and interprets treatment effect measures (OR, RR, RD, HR, NNT) with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen, MOVER, profile likelihood, Bender NNT) and reports marginal vs conditional estimands per FDA 2023 covariate adjustment guidance. Use when reporting treatment effects in confirmatory trials, comparing effect sizes across studies, or constructing forest plots.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Retrieve records from NCBI databases using Biopython Bio.Entrez (EFetch, ESummary). Use when downloading sequences, fetching GenBank/GenPept records, getting document summaries, parsing nested XML, navigating GI deprecation, choosing between rettype+retmode combinations, and parsing into Biopython SeqRecord/SwissProt objects. Covers nucleotide, protein, gene, pubmed, sra, gds, taxonomy, snp, clinvar.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Differentially methylated region (DMR) detection using methylKit tiles, bsseq BSmooth, and DMRcate. Use when identifying contiguous genomic regions with methylation differences between experimental conditions or cell types.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Extract, filter, annotate, and export differential expression results from DESeq2 or edgeR. Use for identifying significant genes, applying multiple testing corrections, adding gene annotations, and preparing results for downstream analysis. Use when filtering and exporting DE analysis results.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Create portable, standards-based bioinformatics pipelines with Common Workflow Language (CWL). Use when building workflows that need maximum portability across execution platforms, sharing pipelines with collaborators using different systems, or contributing to community workflow registries.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Alpha and beta diversity analysis for microbiome data. Calculate within-sample richness, evenness, and between-sample dissimilarity with phyloseq and vegan. Use when comparing community composition across samples or testing for group differences in microbiome structure.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Generate consensus FASTA sequences by applying VCF variants to a reference using bcftools consensus. Use when creating sample-specific reference sequences or reconstructing haplotypes.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
End-to-end pooled and single-cell CRISPR screen analysis from FASTQ to hit genes. Orchestrates library design QC, guide counting, six-stage screen QC (plasmid Gini, replicate Pearson, CEGv2 PR-AUC, copy-number artifact), method-appropriate hit calling across MAGeCK RRA/MLE, BAGEL2, drugZ, JACKS, and Chronos, cancer-cell-line copy-number correction (CRISPRcleanR / Chronos), batch correction for multi-batch screens, and the specialized branches for combinatorial paralog screens, single-cell Perturb-seq, base-editor variant-function screens, prime-editor screens, and in vivo bottleneck-aware screens. Use when analyzing any pooled CRISPR screen end-to-end, choosing the correct hit-calling method by experimental design, integrating copy-number correction into the pipeline, or branching the workflow for single-cell, combinatorial, base-editor, prime-editor, or in vivo variants.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Quantifies CRISPR editing outcomes with CRISPResso2 (Clement 2019 Nat Biotechnol) across Cas9-nuclease (indels, HDR), CBE and ABE base editors (target conversion + bystander), and prime editor (pegRNA-templated) modes. Covers single-amplicon (CRISPResso), multi-sample batch (CRISPRessoBatch), pooled-amplicon (CRISPRessoPooled), WGS off-target (CRISPRessoWGS), and sample-comparison (CRISPRessoCompare) workflows; quantification-window math that controls what is called edited; substitution-vs-indel diagnostic to distinguish BE from Cas9 contamination; MMEJ deletion pattern interpretation; allele-frequency tables; and failure modes from amplicon misalignment or contamination. Use when quantifying editing from amplicon sequencing, choosing CRISPResso mode by design, distinguishing intended edits from bystanders and indel byproducts, debugging low-alignment runs, or generating publication-grade editing reports.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Designs covalent inhibitors and warheads targeting cysteine (most common, 98% of covalent drugs), lysine, serine, threonine, tyrosine, and aspartate residues, with explicit handling of warhead reactivity (acrylamide, chloroacetamide, vinyl sulfone, sulfonyl fluoride, fluorosulfate, aldehyde, boronate, nitrile), reversibility (kinact/Ki, t_residence), glutathione (GSH) stability, intrinsic reactivity assays, and covalent docking (DOCKovalent, GOLD, HCovDock). Use when designing covalent inhibitors for targeted covalent inhibition (TCI), KRAS G12C-style approaches, or rationalizing covalent SAR.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Plot per-group distributions of continuous data using boxplots, violins, beeswarms, quasirandom jitter, and raincloud plots with sample-size honesty (Weissgerber 2015), KDE-bandwidth awareness, and N-aware encoding choices. Use when comparing distributions across a small number of groups — expression per cluster, biomarker per arm, scores per condition — and the bar-of-mean default is misleading.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Load gene expression count matrices from various formats including CSV, TSV, featureCounts, Salmon, kallisto, and 10X. Use when importing quantification results for downstream analysis.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
End-to-end CRISPR experiment design from target selection to delivery-ready constructs. Covers guide RNA design, off-target assessment, and specialized editing strategies including knockouts, base editing, and HDR knockins. Use when designing complete CRISPR editing experiments for gene knockout, correction, or tagging.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Detect single-nucleotide crosslink (CL) sites in CLIP-seq data using truncation patterns (iCLIP/eCLIP CITS), crosslink-induced mutations (HITS-CLIP CIMS deletions, PAR-CLIP T-to-C), or HMM/kernel-density methods (PureCLIP, PARalyzer, CTK). Use when single-nucleotide resolution is required for motif registration (mCross), allele-specific binding (BEAPR), variant-effect prediction, or comparing crosslink chemistry across CLIP variants.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트
Detects somatic mutations in circulating tumor DNA using variant callers optimized for low allele fractions with UMI-based error suppression. Reliably detects mutations at VAF above 0.5 percent using consensus-based approaches. Use when identifying tumor mutations from plasma DNA or tracking specific variants.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
BioTender-max/awesome-bio-agent-skills☆ 2022026년 7월 2일 업데이트